tiprankstipranks
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market

Recursion Pharmaceuticals (RXRX) Income Statement

Compare
3,024 Followers

Recursion Pharmaceuticals Income Statement

Last quarter (Q4 2024), Recursion Pharmaceuticals's total revenue was $4.51M, a decrease of -58.58% from the same quarter last year. In Q4, Recursion Pharmaceuticals's net income was $-178.91M. See Recursion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 58.84M$ 44.58M$ 39.68M$ 10.00M$ 3.41M
Gross Profit
$ 13.60M$ 1.99M$ -8.59M$ 896.00K$ -59.91M
Operating Expenses
$ 492.61M$ 351.35M$ 237.13M$ 192.78M$ 88.03M
Depreciation and Amortization
$ 36.49M$ 24.40M$ 19.49M$ 9.10M$ 4.44M
EBITDA
$ -426.72M$ -299.57M$ -227.66M$ -174.42M$ -81.70M
Operating Income
$ -479.00M$ -350.06M$ -245.73M$ -182.78M$ -84.61M
Other Income/Expenses
$ 14.22M$ 17.93M$ 6.25M$ -3.70M$ -2.39M
Pretax Income
$ -464.79M$ -332.13M$ -239.48M$ -186.48M$ -87.01M
Net Income
$ -463.66M$ -328.07M$ -239.42M$ -178.07M$ -87.88M
Per Share Metrics
Basic EPS
$ -1.69$ -1.58$ -1.36$ -1.05$ -0.52
Diluted EPS
$ -1.69$ -1.58$ -1.36$ -1.05$ -0.52
Weighted Average Shares Outstanding
274.21M 207.85M 175.54M 170.27M 165.79M
Weighted Average Shares Outstanding (Diluted)
274.21M 207.85M 175.54M 170.27M 165.79M
Currency in USD

Recursion Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis